BPC-157 10mg

Description

Research-Grade BPC-157 Peptide for Sale | 10mg Lyophilised Powder | ≥99% Purity | 48-Hour Delivery Across EU & UK

---

BPC-157: The Advanced Body Protection Compound for Cutting-Edge Research

Buy BPC-157 10mg EU & UK, eupeptidelap.co.uk is proud to present BPC-157 10mg, a premium research-grade pentadecapeptide manufactured to the highest analytical standards. As a trusted peptide vendor uk and leading EU peptide supplier, we provide researchers across Europe with BPC-157 for sale that delivers exceptional purity, consistency, and documented quality for advanced studies in tissue regeneration, angiogenesis, and inflammation research .

BPC-157 (Body Protection Compound-157) is a 15-amino acid synthetic peptide with the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val and a molecular weight of approximately 1419.58 g/mol . It is derived from a protective protein found in human gastric juice and has been the subject of extensive preclinical research for its remarkable regenerative properties . The peptide demonstrates exceptional pharmacodynamic potency at nanomolar doses and remarkable biostability—resisting hydrolysis, enzymatic degradation, and gastric fluid while maintaining activity at room temperature .

A landmark study published in Cell Communication and Signaling (2026) has elucidated a primary molecular mechanism underlying BPC-157’s proangiogenic effects . Researchers identified that intracellular BPC-157 engages the E3 ubiquitin ligase adaptor protein FBXO22 through its proline residue at position 3. This interaction suppresses the ubiquitination and subsequent proteasomal degradation of the transcription factor BACH1, leading to its stabilisation. The consequent accumulation of BACH1 enhances critical processes in vascular regeneration, namely the proliferation and tube-forming capacity of vascular endothelial cells. Buy BPC-157 10mg EU & UK

For researchers seeking to buy peptide online EU for investigations into tissue repair, wound healing, gastrointestinal health, or angiogenesis pathways, eupeptidelap.co.uk offers this premium research compound with comprehensive documentation, including Certificates of Analysis and batch-specific purity data . Whether your laboratory is based in London, Berlin, Paris, or anywhere in the European Union, our guaranteed 48 hour delivery peptide service ensures your research continues without interruption. Buy BPC-157 10mg EU & UK

---

The Scientific Foundation of BPC-157 Research

Discovery and Molecular Characterisation

BPC-157 was originally identified as a naturally occurring peptide endogenous to human gastric juice that promotes mucosal integrity and homeostasis . Over three decades of research, the peptide’s applications have expanded far beyond gastrointestinal healing to encompass musculoskeletal repair, wound healing, angiogenesis, and neuroprotection .

The peptide exhibits exceptional stability characteristics. It is remarkably resistant to enzymatic degradation, maintaining its biological activity in human gastric juice for more than 24 hours, and is stable at room temperature . This stability, combined with its broad biological effects, positions BPC-157 as a highly promising candidate for tissue injury research .

Mechanism of Action: The FBXO22-BACH1 Axis

A groundbreaking study published in 2026 has elucidated a primary molecular mechanism underlying BPC-157’s proangiogenic effects . Using biotin-labeled BPC-157 and co-immunoprecipitation assays followed by mass spectrometry, researchers identified FBXO22 as the strongest interactor with BPC-157 .

Key mechanistic findings include:

• Direct Protein Interaction: Immunoprecipitation confirmed that BPC-157 specifically binds FBXO22 in a concentration-dependent manner. Immunofluorescence and ELISA further demonstrated the intracellular colocalisation of BPC-157 with FBXO22 .

• Molecular Docking: Molecular docking simulations predicted a stable binding conformation with electrostatic interactions dominating the binding interface. Hydrogen bonding was observed between residues G1, E2, P3, K7, and V15 of BPC-157 and E31, R58, and E183 of FBXO22 .

• Proline Residue Key Binding Site: Alanine-scanning mutagenesis confirmed that the proline residue at position 3 serves as the critical binding site for FBXO22 .

• BACH1 Stabilisation: This interaction suppresses the ubiquitination and proteasomal degradation of the transcription factor BACH1, leading to significant stabilisation of BACH1 protein levels .

• Enhanced Angiogenesis: BACH1 accumulation then enhances the proliferation and tube-forming capacity of vascular endothelial cells, driving angiogenesis and tissue repair .

Additional Molecular Pathways

Beyond the FBXO22-BACH1 axis, BPC-157 exerts its effects through multiple interconnected pathways :

• Growth Factor Modulation: BPC-157 significantly upregulates the expression of PDGF subunit B (PDGFB), FGF2, FGF receptor (FGFR), and EGF receptor (EGFR) in endothelial cells .

• VEGF Pathway Regulation: The peptide demonstrates a distinctive effect on angiogenesis—promoting it where needed for healing, yet opposing pathological angiogenesis such as corneal neovascularisation .

• NO-System Control: BPC-157 modulates nitric oxide levels, either increasing or decreasing them as circumstances require, while consistently counteracting free radical formation .

• Gene Expression Feedback: BPC-157 simultaneously stimulates expression of the egr-1 gene and its repressor nab2, establishing an immediate negative feedback loop that may be key to its prompt healing effects .

---

Key Research Applications

Angiogenesis and Vascular Research

BPC-157 has demonstrated remarkable proangiogenic effects across multiple experimental models :

• Quantitative Evidence: Comparative angiogenic profiling through CD31 immunohistochemistry revealed a dose-dependent increase in microvascular density in BPC-157-treated rodent skeletal muscle contusion models (1.7 ± 0.4 vessels in controls vs. 6.2 ± 3.2 in the BPC-157-treated group, p < 0.001) .

• Multiple Tissue Validation: This neovascularisation phenomenon was consistently observed in murine full-thickness burn injuries and rat dermal incisional wounds, suggesting BPC-157 plays a fundamental role in promoting endothelial cell proliferation and vascular network reconstitution during tissue repair .

• Controlled Angiogenesis: Importantly, BPC-157 resolves the “angiogenic privilege” of the cornea—promoting healing while maintaining transparency and opposing pathological neovascularisation, demonstrating its ability to balance competing proangiogenic and antiangiogenic mediators .

Cell Proliferation and Tube Formation Studies

In human umbilical vein endothelial cells (HUVECs), BPC-157 demonstrates significant bioactivity :

• Enhanced Cell Viability: Treatment with 5 µg/mL, 10 µg/mL, or 20 µg/mL BPC-157 significantly enhanced HUVEC viability in a concentration-dependent manner .

• Tube Formation Stimulation: HUVECs plated on Matrigel with increasing concentrations of BPC-157 formed more extensive tubes in a dose-dependent manner .

• Growth Factor Upregulation: BPC-157 significantly upregulated PDGFB, FGF2, FGFR, and EGFR expression .

Musculoskeletal and Connective Tissue Research

BPC-157 has been extensively studied in models of tendon, ligament, and muscle healing :

• Tendon Healing: In rodent models of muscle contusion, quantitative histomorphometry showed improved new collagen fiber formation rates and interfiber spacing recovery (0.62 ± 0.21 μm vs. 0.18 ± 0.15 μm, p < 0.005) .

• Wound Healing Efficacy: Systematic pharmacodynamic evaluations using murine full-thickness burn injuries, rat dermal incisional wounds, and rodent skeletal muscle contusion models demonstrated significant therapeutic efficacy in accelerating tissue regeneration .

• Soft Tissue Repair: The peptide promotes the repair of damaged muscles, tendons, and ligaments, with research suggesting improved healing quality and reduced scar tissue formation .

Gastrointestinal Research

Consistent with its origin from gastric tissue preparations, BPC-157 has demonstrated particular efficacy in gastrointestinal pathology research :

• Mucosal Protection: The peptide exerts significant protective effects on the esophagus, stomach, duodenum, and colorectal mucosa .

• Ulcer Healing: It promotes healing of gastrointestinal ulcers, anastomotic sites, and various GI fistulas .

• Inflammatory Bowel Disease Models: BPC-157 has shown substantial therapeutic potential in experimental models of inflammatory bowel disease .

Anti-Inflammatory Research

BPC-157 exerts meaningful anti-inflammatory effects through multiple mechanisms :

• Cytokine Modulation: The peptide modulates inflammatory cytokine profiles and promotes resolution pathways .

• Oxidative Stress Reduction: BPC-157 consistently counteracts free radical formation, even when modulating NO levels .

• Safety Profile: Preclinical safety studies have shown no adverse effects across several organ systems, with LD1 not achieved . Phase I and II clinical studies have been conducted in conditions including ulcerative colitis, knee pain, and interstitial cystitis .

Neuroprotective Research

Emerging evidence supports BPC-157’s neuroprotective properties :

• Neurodegenerative Disease Models: BPC-157 therapy counteracts Parkinson’s disease-like and Alzheimer’s disease-like disturbances in acknowledged animal models .

• Neurotransmitter Modulation: The peptide demonstrates neurotransmitter-like activity, counteracting disturbances in dopamine, serotonin, glutamate, GABA, and acetylcholine systems .

---

Quality Assurance: Setting the Standard for Research Compounds

Manufacturing Excellence

eupeptidelap.co.uk sources BPC-157 10mg from certified GMP facilities with rigorous quality control protocols :

• HPLC Purity Analysis: >99.1% purity verified by high-performance liquid chromatography .

• Mass Spectrometry Verification: Molecular weight confirmation via LC-HRMS consistent with the peptide structure.

• Batch-Specific Certificates of Analysis: Complete documentation for each production run .

• Sterile Manufacturing: Lyophilised with no additives; sterile filtered.

• Research-Use Only (RUO) Labelling: Full compliance with research compound regulations.

Chemical and Product Specifications

Stability and Handling Guidelines

Lyophilised Powder Storage: Store lyophilised BPC-157 powder at -20°C in a dry, dark environment, protected from light and moisture . Under proper storage conditions, the powder maintains stability for up to 24 months from the date of manufacture.

Reconstitution Protocol:

1. Allow vial and solvent to reach ambient temperature before opening to prevent condensation.

2. Reconstitute using sterile bacteriostatic water or suitable solvent according to research protocol.

3. Inject solvent slowly down the inside wall of the vial to minimise foaming.

4. Gently swirl or roll the vial until fully dissolved—do not shake vigorously.

5. Label the vial with the date of reconstitution.

6. Refrigerate immediately at 2-8°C.

Reconstituted Solution Storage: Store reconstituted BPC-157 at 2-8°C for short-term use. For longer-term storage, aliquot into single-use portions and store at -20°C. Avoid repeated freeze-thaw cycles.

Protection from Light and Moisture:

• Store in original packaging protected from light.

• Keep vials tightly sealed when not in use.

• Allow refrigerated vials to reach room temperature before opening to prevent condensation.

Key Benefits

• Premium Quality Manufacturing: GMP-certified production, >99.1% HPLC-verified purity with lot-specific COAs .

• Well-Characterised Mechanism: Novel FBXO22-BACH1 axis elucidated in 2026 research provides clear molecular understanding .

• Angiogenesis Stimulation: Increases microvascular density from 1.7 to 6.2 vessels (p < 0.001) in muscle contusion models .

• Endothelial Cell Proliferation: Enhances HUVEC viability in concentration-dependent manner .

• Tube Formation Enhancement: Promotes capillary-like structure formation on Matrigel .

• Growth Factor Upregulation: Increases PDGFB, FGF2, FGFR, and EGFR expression .

• Controlled Angiogenesis: Resolves corneal healing while maintaining angiogenic privilege .

• NO-System Modulation: Balances nitric oxide effects while counteracting free radical formation .

• Gene Expression Feedback: Establishes immediate negative feedback loop between egr-1 and nab2 .

• Musculoskeletal Recovery: Accelerates tendon, ligament, and muscle healing .

• Gastrointestinal Research: Extensive evidence in ulcer and GI injury models .

• Anti-Inflammatory Properties: Modulates inflammatory cytokines and reduces oxidative stress .

• Neuroprotective Effects: Counteracts Parkinson’s and Alzheimer’s-like disturbances in animal models .

• Favourable Safety Profile: No adverse effects in preclinical studies; LD1 not achieved . Phase I/II clinical studies conducted .

• Comprehensive Documentation: Certificates of Analysis with batch-specific purity data .

• 48-Hour EU & UK Delivery: Rapid shipping to research facilities across Europe.

• Batch Consistency: Rigorous quality control ensures lot-to-lot reproducibility.

• EU Sourced: Available from within the European Union.

---

Frequently Asked Questions

Q: What is BPC-157 and where does it come from?

A: BPC-157 (Body Protection Compound-157) is a 15-amino acid synthetic peptide (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) derived from a protective protein found in human gastric juice . It has been extensively studied for its tissue-protective and regenerative properties .

Q: What is the mechanism of action of BPC-157?

A: BPC-157 binds to FBXO22 through its proline residue at position 3, suppressing the ubiquitination and degradation of the transcription factor BACH1 . BACH1 stabilisation enhances endothelial cell proliferation and tube formation, driving angiogenesis and tissue repair. The peptide also upregulates growth factors (PDGFB, FGF2, FGFR, EGFR) and modulates the NO system .

Q: What purity level can I expect when I buy BPC-157 from eupeptidelap.co.uk?

A: All BPC-157 10mg from eupeptidelap.co.uk is tested to >99.1% purity by HPLC, with Certificates of Analysis provided with every order . Each batch is individually analysed, ensuring you receive material suitable for rigorous research applications.

Q: What is the molecular weight and CAS number of BPC-157?

A: BPC-157 has a molecular weight of approximately 1419.58 g/mol and CAS number 137525-51-0. Its molecular formula is C₆₂H₉₈N₁₆O₂₂ .

Q: How should I store BPC-157 for long-term stability?

A: Store lyophilised BPC-157 powder at -20°C in a dry, dark environment, protected from light and moisture . The peptide is stable at room temperature for short periods but should be kept frozen for extended storage. After reconstitution, store at 2-8°C for short-term use. For longer-term storage, aliquot into single-use portions and store at -20°C. Avoid repeated freeze-thaw cycles.

Q: What is the recommended reconstitution protocol for BPC-157?

A: Reconstitute using sterile bacteriostatic water or suitable solvent according to research protocol . Allow vial and solvent to reach ambient temperature before opening, inject solvent slowly down the vial wall to minimise foaming, and gently swirl until dissolved—do not shake vigorously.

Q: What research areas commonly use BPC-157?

A: BPC-157 is widely used in angiogenesis and vascular research , cell proliferation studies , musculoskeletal and connective tissue research (tendon, ligament, muscle healing) , wound healing research , gastrointestinal research , anti-inflammatory research , and neuroprotective studies .

Q: What is the evidence for BPC-157’s effects on angiogenesis?

A: A 2026 study published in Cell Communication and Signaling demonstrated that BPC-157 significantly increases microvascular density in muscle contusion models (1.7 ± 0.4 vessels in controls vs. 6.2 ± 3.2 in treated groups, p < 0.001) . The peptide promotes endothelial cell proliferation and tube formation through the FBXO22-BACH1 pathway .

Q: Do you ship BPC-157 to EU countries?

A: Yes. As a dedicated EU peptide supplier, we ship BPC-157 10mg to all European Union member states with our guaranteed 48 hour delivery peptide service. Our EU fulfilment centre ensures rapid delivery without customs delays. All shipments use protective packaging to maintain compound integrity during transit.

Q: What documentation do you provide with BPC-157 orders?

A: Every order includes a Certificate of Analysis (COA) with batch-specific purity data . Additional documentation, including HPLC chromatograms and mass spectrometry data, is available upon request for researchers requiring comprehensive analytical verification.

Q: Is BPC-157 legal to purchase for research in the UK and EU?

A: In the EU and UK, BPC-157 is legal to purchase for research purposes when properly labelled and supplied to qualified buyers such as laboratories and research facilities . It cannot be marketed or sold as a supplement, cosmetic, or medical treatment without approval from the EMA or MHRA. At eupeptidelap.co.uk, all products are intended for research and laboratory use only and are not for human consumption .

Q: Does BPC-157 affect other biological pathways?

A: Yes, BPC-157 demonstrates pleiotropic effects, modulating multiple systems including NO, VEGF, growth factors, and gene expression pathways . Importantly, it consistently counteracts free radical formation and maintains essential protective functions .

Q: Has BPC-157 been studied in clinical trials?

A: Yes, phase I and phase II clinical studies have been conducted in conditions including ulcerative colitis, knee pain, and interstitial cystitis, aligning with the beneficial effects observed in animal experiments . Preclinical safety studies have shown no adverse effects, with LD1 not achieved .

Q: Do you offer bulk quantities of BPC-157 for institutional research?

A: Yes. We accommodate bulk orders for research institutions. Contact our team at sales@eupeptidelap.co.uk for volume pricing, custom requirements, and supply agreements for ongoing research programs. ...........................................

---

Advance Your Research with BPC-157 10mg

eupeptidelap.co.uk is your trusted source for BPC-157 10mg, the premium choice for researchers investigating tissue regeneration, angiogenesis, gastrointestinal health, and wound healing mechanisms. With a newly elucidated molecular mechanism involving the FBXO22-BACH1 axis and decades of preclinical research supporting its cytoprotective and regenerative properties, BPC-157 represents one of the most extensively studied and versatile peptides in the research community .

Whether you are exploring angiogenesis pathways, designing wound healing studies, investigating inflammatory bowel disease, or researching musculoskeletal recovery mechanisms, our rigorously tested compound provides the quality and consistency your work demands.  .  .  .  .  . .   .  .  . . . . . . . . . . . . . . . . . . . . . . . .  . . . . . . . . . 

Order today and experience the eupeptidelap.co.uk difference – premium quality, rapid 48-hour delivery across the EU and UK, and expert support for the European research community.